Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04746833 · ClinicalTrials.gov registry record · NA
Development/Testing of SUMMIT: a Tool to Help Patients Manage Pain While Tapering Opioids
A NA study of Chronic Pain, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 4
- Study locations
NCT04746833: Completed NA study of Chronic Pain, sponsored by VA Office of Research and Development.
NCT04746833 is a NA study of Chronic Pain that has completed, run by VA Office of Research and Development. The registered enrollment target is 44 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04746833, a NA study of Chronic Pain, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 4
- Study locations
Study Summary
There are nearly one million veterans being treated with long-term opioid therapy (LTOT) for chronic pain. Numerous short and long-term harms associated with LTOT and mounting evidence suggest they have modest or no benefit. Yet, currently available resources to support veterans to taper are inadequate. Primary care, where most LTOT in VHA is prescribed, is overburdened and straining to meet the challenge of caring for patients with chronic pain. A scalable, relatively inexpensive tapering intervention to support primary care and/or to extend the reach of resource-intensive specialty clinics would be of great benefit to veterans who are not deriving sufficient benefit from LTOT. As such, the goal of this study is to develop and test an interactive, theory-informed, multi-component mobile website to enable veterans to safely taper opioids while managing their pain.
Primary Outcome
Morphine milligram equivalents per day based on participant self report.
Conditions Studied
Interventions
- BEHAVIORAL control
- BEHAVIORAL SUMMIT
Study Locations (4)
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
Massachusetts
- VA Central Western Massachusetts Healthcare System, Leeds, MA - Leeds
Pennsylvania
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA - Philadelphia
Utah
- VA Salt Lake City Health Care System, Salt Lake City, UT - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-03-24 |
| Est. Completion | 2023-11-30 |
| Phase | NA |
What the finished NCT04746833 record still lists
NCT04746833 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which control is the first listed.
NCT04746833 reports a single indexed study location in Connecticut, Massachusetts, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04746833 about?
NCT04746833 is a clinical study titled "Development/Testing of SUMMIT: a Tool to Help Patients Manage Pain While Tapering Opioids". There are nearly one million veterans being treated with long-term opioid therapy (LTOT) for chronic pain. Numerous short and long-term harms associated with LTOT and mounting evidence suggest they have modest or no benefit. Yet, currently available resources to support veterans to taper are inadequ...
What is the current status of trial NCT04746833?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2021-03-24. Estimated completion is 2023-11-30.
What conditions does trial NCT04746833 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT04746833?
The interventions under investigation include: control (BEHAVIORAL), SUMMIT (BEHAVIORAL).
Who is sponsoring clinical trial NCT04746833?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04746833 being conducted?
This trial has 4 study locations across Connecticut, Massachusetts, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04746833's enrollment target sits among peer trials
44 208th of 301 higher than 92 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI